Nafcillin: Difference between revisions
m (Protected "Nafcillin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
||
| Line 19: | Line 19: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
'''Nafcillin sodium''' is a [[narrow-spectrum antibiotic|narrow spectrum]] [[beta-lactam antibiotic]] of the [[penicillin]] class. As a [[beta-lactamase]]-resistant penicillin, it is used to treat [[infections]] caused by [[Gram-positive]] [[bacteria]], particularly [[species]] of [[Staphylococci]], that are [[antibiotic resistance|resistant]] to other penicillins. | '''Nafcillin sodium''' is a [[narrow-spectrum antibiotic|narrow spectrum]] [[beta-lactam antibiotic]] of the [[penicillin]] class. As a [[beta-lactamase]]-resistant penicillin, it is used to treat [[infections]] caused by [[Gram-positive]] [[bacteria]], particularly [[species]] of [[Staphylococci]], that are [[antibiotic resistance|resistant]] to other penicillins. | ||
| Line 36: | Line 36: | ||
[[Category: Beta-lactam antibiotics]] | [[Category: Beta-lactam antibiotics]] | ||
{{WH}} | {{WH}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 14:10, 20 August 2012
| File:Nafcillin.svg | |
| Clinical data | |
|---|---|
| Routes of administration | IM, IV |
| Pharmacokinetic data | |
| Protein binding | 90% |
| Metabolism | <30% hepatic |
| Excretion | Biliary and renal |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C21H22N2O5S |
| Molar mass | 414.476 g/mol |
|
WikiDoc Resources for Nafcillin |
|
Articles |
|---|
|
Most recent articles on Nafcillin |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Nafcillin at Clinical Trials.gov Clinical Trials on Nafcillin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Nafcillin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Nafcillin Discussion groups on Nafcillin Directions to Hospitals Treating Nafcillin Risk calculators and risk factors for Nafcillin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Nafcillin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Nafcillin sodium is a narrow spectrum beta-lactam antibiotic of the penicillin class. As a beta-lactamase-resistant penicillin, it is used to treat infections caused by Gram-positive bacteria, particularly species of Staphylococci, that are resistant to other penicillins.
Side effects
As with all penicillins, serious life-threatening allergic reactions can occur.
Milder side effects include:
- Nausea and vomiting
- Diarrhea, often due to suppression of normal gastrointestinal bacteria. Occasionally, this leads to a more serious super-infection with an organism like Clostridium difficile
- Abdominal pain
- Yeast infections (thrush) affecting the mouth and tongue or vagina
- Pages with script errors
- Pages with broken file links
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Beta-lactam antibiotics